About Daxor
Daxor is a company based in New York (United States) founded in 1970.. Daxor offers products and services including BVA-100. Daxor operates in a competitive market with competitors including Hemcheck, Pathshodh Healthcare, Cellmic, Epocal and Essenlix, among others.
- Headquarter New York, United States
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Daxor Corporation
-
Annual Revenue
$-135.67 K-100.39as on Dec 31, 2024
-
Net Profit
$536.33 K91.11as on Dec 31, 2024
-
EBITDA
$621.42 K88.46as on Dec 31, 2024
-
Latest Funding Round
$305 K (USD), Grant
Sep 11, 2023
-
Investors
HHS
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Daxor
Daxor is a publicly listed company on the NASDAQ with ticker symbol DXR in USA, operating in the Miscellaneous sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Daxor
Daxor offers a comprehensive portfolio of products and services, including BVA-100. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Device for accurate blood volume measurement in medical diagnostics.
Unlock access to complete
Unlock access to complete
Funding Insights of Daxor
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $305,000
-
First Round
First Round
(20 Jul 2020)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2023 | Amount | Grant - Daxor | Valuation |
investors |
|
| Sep, 2023 | Amount | Grant - Daxor | Valuation |
investors |
|
| Aug, 2021 | Amount | Grant - Daxor | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Daxor
Daxor has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and National Institute of General Medical Sciences. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Basic research is supported to advance medical sciences.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Daxor
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Daxor
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Daxor Comparisons
Competitors of Daxor
Daxor operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hemcheck, Pathshodh Healthcare, Cellmic, Epocal and Essenlix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Devices for detecting hemolyzed blood samples are provided by Hemcheck.
|
|
| domain | founded_year | HQ Location |
Developer of handheld medical diagnostic devices. This company develops and manufactures portable devices for measuring multiple biomarkers related to diabetes, kidney disease, anemia, malnutrition, and liver ailments. The devices provide rapid, point-of-care diagnostic testing, enabling healthcare professionals to obtain results quickly. The technology aims to improve healthcare access and affordability.
|
|
| domain | founded_year | HQ Location |
Rapid test readers are developed for chromatographic and fluorescent assays.
|
|
| domain | founded_year | HQ Location |
Biochips and solid-state diagnostic devices for blood testing are developed.
|
|
| domain | founded_year | HQ Location |
Mobile health self-test platform is provided using nanotechnology and AI.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Daxor
Frequently Asked Questions about Daxor
When was Daxor founded?
Daxor was founded in 1970 and raised its 1st funding round 50 years after it was founded.
Where is Daxor located?
Daxor is headquartered in New York, United States. It is registered at New York, New York, United States.
What does Daxor do?
Daxor was founded in 1970 in New York, United States, and operates in the medical device sector. The BVA-100 blood volume analyzer is produced by the company, with measurements completed in under 60 minutes. This tool is utilized to assess blood volume and support treatment decisions for conditions including congestive heart failure, anemia, hypertension, and dialysis needs. Operations focus on healthcare diagnostics across the United States.
Who are the top competitors of Daxor?
Daxor's top competitors include Pathshodh Healthcare, Cellmic and Hemcheck.
What products or services does Daxor offer?
Daxor offers BVA-100.
Is Daxor publicly traded?
Yes, Daxor is publicly traded on NASDAQ under the ticker symbol DXR.
Who are Daxor's investors?
Daxor has 2 investors. Key investors include HHS, and National Institute of General Medical Sciences.
What is Daxor's ticker symbol?
The ticker symbol of Daxor is DXR on NASDAQ.